About 6,240 results

ALLMedicine™ Diphtheria Center

Research & Reviews  1,890 results

Cost-effectiveness of pertussis booster vaccination for preschool children in Japan.
Vaccine Tanaka M, Okubo R et. al.

Jan 19th, 2022 - Japan currently recommends four doses of the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in its routine vaccination program, but the introduction of a fifth dose is currently under consideration. An objective of the booster vaccination i...

COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Me...
Vaccine Walker B, Anderson A et. al.

Jan 17th, 2022 - The COVID-19 pandemic disrupted routine vaccinations for children and adolescents. However, it remains unclear whether the impact has been different for children and adolescents from low-income families. To address this, we compared monthly routin...

Diphtheria resurgence in Sada'a-Yemen, 2017-2020.
BMC Infectious Diseases; Al-Dar AA, Al-Qassimi M et. al.

Jan 13th, 2022 - Diphtheria is a contagious vaccine-preventable disease that contributes to the high morbidity and mortality among under 5 children, especially in Yemen. As a consequence of war and collapse of the health system, a fatal epidemic occurred at the en...

A school-based educational on-site vaccination intervention for adolescents in an urban...
BMC Public Health; Bethke N, Gellert P et. al.

Jan 12th, 2022 - Vaccination rates for measles, mumps, and rubella (MMR) and diphtheria, tetanus, pertussis, and polio (Tdap-IPV) are not optimal among German adolescents. Education in combination with easy access to vaccination may be a promising approach to impr...

see more →

Guidelines  13 results

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Upd...
MMWR. Morbidity and Mortality Weekly Report; Havers FP, Moro PL et. al.

Jan 24th, 2020 - Since 2005, a single dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine has been recommended by the Advisory Committee on Immunization Practices (ACIP) for adolescents and adults (1,2). After receipt of Tdap,...

ACOG Committee Opinion No. 741 Summary: Maternal Immunization.
Obstetrics and Gynecology;

May 26th, 2018 - Immunization is an essential part of care for adults, including pregnant women. Influenza vaccination for pregnant women is especially important because pregnant women who contract influenza are at greater risk of maternal morbidity and mortality ...

Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Re...
MMWR. Recommendations and Reports : Morbidity and Mortali... Liang JL, Tiwari T et. al.

Apr 28th, 2018 - This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria, and pertussis in the United States. As a comprehensive summary of previ...

Committee Opinion No. 718: Update on Immunization and Pregnancy: Tetanus, Diphtheria, a...
Obstetrics and Gynecology;

Aug 24th, 2017 - The overwhelming majority of morbidity and mortality attributable to pertussis infection occurs in infants who are 3 months and younger. Infants do not begin their own vaccine series against pertussis until approximately 2 months of age. This leav...

see more →

Drugs  64 results see all →

Clinicaltrials.gov  77 results

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Jan 4th, 2022 - Phase III study, Randomized, observer blind, lot to lot consistency, non inferiority to PQed typhoid conjugate vaccine and to Typhoid Vi polysaccharide vaccine. Involved participants aged 6 months old to 60 years old.

A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age

Dec 27th, 2021 - The purpose of this study is to evaluate the reactogenicity, safety and immune response of a single intramuscular dose of the respiratory syncytial virus maternal (RSV MAT) vaccine in healthy non-pregnant girls 9-17 years of age (YOA) compared to ...

Healthy, Immunized Communities Study

Dec 21st, 2021 - Vaccines are considered one of the greatest public health successes. Unfortunately, an increasing rate of parental resistance in recent years has led to a reemergence of vaccine-preventable diseases. This project seeks to determine the effect of a...

Increasing Influenza and Tdap Vaccination of Pregnant Women

Nov 11th, 2021 - Infants under 6 months of age at increased risk of both influenza (flu) and pertussis disease, and pregnant women risk serious illness and premature labor from flu. The Advisory Committee on Immunization Practices recommends that women receive a f...

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed

Oct 27th, 2021 - The study will evaluate the safety, immunogenicity,immune persistence and lot-to-lot consistency of Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed, (DTacP) including 2 parts: PART 1 will evaluate the safe...

see more →

News  443 results

Schools, pediatricians look to make up lost ground on non–COVID-19 vaccinations
Kate Ruder, Kaiser Health News

Nov 22nd, 2021 - WESTMINSTER, COLO. – Melissa Blatzer was determined to get her three children caught up on their routine immunizations on a recent Saturday morning at a walk-in clinic in this Denver suburb.

History of diphtheria or tetanus vaccination linked to lower risk for severe COVID-19

Nov 15th, 2021 - Key clinical point: Individuals who had received diphtheria or tetanus vaccinations in the last 10 years were less likely to develop severe COVID-19 compared with those who had not received them. Major finding: The study included 103,049 participa.

Stemness Inhibitor Tested in Rare Hematologic Cancer

Oct 6th, 2021 - Andrew A. Lane, MD, PhD SL-401, a novel therapy that targets a cancer stemness pathway, is being investigated in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) in a phase I/II trial that may pave the way for its approval for t...

Fast Five Quiz: DTaP and Tdap Vaccines

Jul 14th, 2021 - Vaccination series against diphtheria, tetanus, and pertussis (DTaP); tetanus, diphtheria, and pertussis (Tdap); and tetanus and diphtheria (Td) provide necessary protection against these diseases and their associated complications. It is importan...

Tetanus, Diphtheria Boosters Tied to Less Severe COVID-19

Jul 7th, 2021 - (Reuters) - Older individuals who have gotten a diphtheria or tetanus vaccine booster shot in the last 10 years may be at lower risk for severe COVID-19, a new study suggests. Using a large UK registry, researchers looked back at 10 years of immun...

see more →

Patient Education  9 results see all →